BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25898372)

  • 1. Effects of probucol on restenosis after percutaneous coronary intervention: a systematic review and meta-analysis.
    Liu J; Li M; Lu H; Qiao W; Xi D; Luo T; Xiong H; Guo Z
    PLoS One; 2015; 10(4):e0124021. PubMed ID: 25898372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
    Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
    J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.
    Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Hashida K
    Am Heart J; 1996 Jul; 132(1 Pt 1):23-9. PubMed ID: 8701872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduction in the rates of restenosis after coronary angioplasty with simvastatin and probucol].
    Merchán Herrera A; López Mínguez JR; Alonso Ruiz F; Escola JM; Címbora Ortega A; Poblador Curto MA; Redondo Méndez A; Romero Santisteban R; Geniz Gallardo I; González Fernández R; Millán Núñez V
    Rev Esp Cardiol; 1999 Oct; 52(10):778-84. PubMed ID: 10563153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trial.
    Tardif JC; Côté G; Lespérance J; Gosselin G; Joyal M; de Guise P; Bilodeau L; Doucet S; Harel F; Couturier A; Gallo R; Grégoire J
    Can J Cardiol; 2001 Jan; 17(1):49-55. PubMed ID: 11173314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART]).
    Daida H; Kuwabara Y; Yokoi H; Nishikawa H; Takatsu F; Nakata Y; Kutsumi Y; Oshima S; Nishiyama S; Ishiwata S; Kato K; Nishimura S; Miyauchi K; Kanoh T; Yamaguchi H
    Am J Cardiol; 2000 Sep; 86(5):550-2, A9. PubMed ID: 11009277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of AGI-1067 and probucol after percutaneous coronary interventions.
    Tardif JC; Grégoire J; Schwartz L; Title L; Laramée L; Reeves F; Lespérance J; Bourassa MG; L'Allier PL; Glass M; Lambert J; Guertin MC;
    Circulation; 2003 Feb; 107(4):552-8. PubMed ID: 12566365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of restenosis after angioplasty in small coronary arteries with probucol.
    Rodés J; Côté G; Lespérance J; Bourassa MG; Doucet S; Bilodeau L; Bertrand OF; Harel F; Gallo R; Tardif JC
    Circulation; 1998 Feb; 97(5):429-36. PubMed ID: 9490236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial.
    Massberg S; Byrne RA; Kastrati A; Schulz S; Pache J; Hausleiter J; Ibrahim T; Fusaro M; Ott I; Schömig A; Laugwitz KL; Mehilli J;
    Circulation; 2011 Aug; 124(5):624-32. PubMed ID: 21768546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis.
    Sekiya M; Funada J; Watanabe K; Miyagawa M; Akutsu H
    Am J Cardiol; 1998 Jul; 82(2):144-7. PubMed ID: 9678282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.
    Tardif JC; Cöté G; Lespérance J; Bourassa M; Lambert J; Doucet S; Bilodeau L; Nattel S; de Guise P
    N Engl J Med; 1997 Aug; 337(6):365-72. PubMed ID: 9241125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Lee YJ; Daida H; Yokoi H; Miyano H; Takaya J; Sakurai H; Mokuno H; Yamaguchi H
    Jpn Heart J; 1996 May; 37(3):327-32. PubMed ID: 8774625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies.
    Tardif JC; Grégoire J; Lavoie MA; L'Allier PL
    Curr Opin Lipidol; 2003 Dec; 14(6):615-20. PubMed ID: 14624139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    O'Keefe JH; Stone GW; McCallister BD; Maddex C; Ligon R; Kacich RL; Kahn J; Cavero PG; Hartzler GO; McCallister BD
    Am J Cardiol; 1996 Mar; 77(8):649-52. PubMed ID: 8610621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-atherogenic drugs].
    Kanaki T; Saito Y
    Nihon Rinsho; 1998 Oct; 56(10):2635-9. PubMed ID: 9796331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study.
    Fu N; Yang S; Zhang J; Zhang P; Liang M; Cong H; Lin W; Tian F; Lu C
    Int Urol Nephrol; 2018 Jan; 50(1):105-112. PubMed ID: 29071556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty.
    Sirtori CR; Franceschini G
    N Engl J Med; 1997 Dec; 337(26):1918; author reply 1919. PubMed ID: 9417525
    [No Abstract]   [Full Text] [Related]  

  • 18. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.
    Remkes WS; Somi S; Roolvink V; Rasoul S; Ottervanger JP; Gosselink AT; Hoorntje JC; Dambrink JH; de Boer MJ; Suryapranata H; van 't Hof AW;
    JACC Cardiovasc Interv; 2014 Jul; 7(7):751-8. PubMed ID: 25060017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probucol therapy in the prevention of restenosis after successful percutaneous transluminal coronary angioplasty.
    Setsuda M; Inden M; Hiraoka N; Okamoto S; Tanaka H; Okinaka T; Nishimura Y; Okano H; Kouji T; Konishi T
    Clin Ther; 1993; 15(2):374-82. PubMed ID: 8519045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.